You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The lateral flow test is designed to detect immunoglobulin G antibodies against SARS-CoV-2 in a finger prick blood sample and returns results in 20 minutes.
The company's goal is to help laboratories and smaller diagnostic firms accelerate test development and provide end-to-end test design assistance.
Oxsed, a University of Oxford spinout, will continue to focus on prioritizing test access for low- and middle-income countries following the acquisition.
The test detects intact particles by connecting single-stranded DNA with fluorophores to the virus, enabling the detection of a single viral particle.
A clinical evaluation of LamPore, expected to be CE marked shortly, called it promising for high-throughput testing but recommended a more streamlined workflow.
The study currently tests 28,000 people every two weeks and will expand to 150,000 by October, with the aim to increase to 400,000 people across the country.
The test was developed by a consortium founded in April by Omega Diagnostics, Abingdon Health, BBI Solutions, CIGA Healthcare, and the University of Oxford.
Data generated via the platform will be used to inform UK National Health Service policy.
University of Oxford said the program will assemble experts with experience in generating the robust evidence required for a test to be used in the UK NHS.